
[ Wed, Dec 19th 2018 ]: WOPRAI
[ Wed, Dec 19th 2018 ]: WOPRAI
[ Wed, Dec 19th 2018 ]: WOPRAI
[ Wed, Dec 19th 2018 ]: WOPRAI
[ Wed, Dec 19th 2018 ]: WOPRAI
[ Wed, Dec 19th 2018 ]: WOPRAI
[ Wed, Dec 19th 2018 ]: WOPRAI
[ Wed, Dec 19th 2018 ]: WOPRAI
[ Wed, Dec 19th 2018 ]: WOPRAI
[ Wed, Dec 19th 2018 ]: WOPRAI

[ Tue, Dec 18th 2018 ]: WOPRAI
[ Tue, Dec 18th 2018 ]: WOPRAI
[ Tue, Dec 18th 2018 ]: WOPRAI
[ Tue, Dec 18th 2018 ]: WOPRAI
[ Tue, Dec 18th 2018 ]: WOPRAI
[ Tue, Dec 18th 2018 ]: WOPRAI
[ Tue, Dec 18th 2018 ]: WOPRAI
[ Tue, Dec 18th 2018 ]: WOPRAI
[ Tue, Dec 18th 2018 ]: WOPRAI
[ Tue, Dec 18th 2018 ]: WOPRAI

[ Mon, Dec 17th 2018 ]: WOPRAI
[ Mon, Dec 17th 2018 ]: WOPRAI
[ Mon, Dec 17th 2018 ]: WOPRAI
[ Mon, Dec 17th 2018 ]: WOPRAI
[ Mon, Dec 17th 2018 ]: WOPRAI
[ Mon, Dec 17th 2018 ]: WOPRAI
[ Mon, Dec 17th 2018 ]: WOPRAI
[ Mon, Dec 17th 2018 ]: WOPRAI
[ Mon, Dec 17th 2018 ]: WOPRAI
[ Mon, Dec 17th 2018 ]: WOPRAI

[ Fri, Dec 14th 2018 ]: WOPRAI
[ Fri, Dec 14th 2018 ]: WOPRAI
[ Fri, Dec 14th 2018 ]: WOPRAI
[ Fri, Dec 14th 2018 ]: WOPRAI
[ Fri, Dec 14th 2018 ]: WOPRAI
[ Fri, Dec 14th 2018 ]: WOPRAI
[ Fri, Dec 14th 2018 ]: WOPRAI
[ Fri, Dec 14th 2018 ]: WOPRAI
[ Fri, Dec 14th 2018 ]: WOPRAI

[ Thu, Dec 13th 2018 ]: WOPRAI
[ Thu, Dec 13th 2018 ]: WOPRAI
[ Thu, Dec 13th 2018 ]: WOPRAI
[ Thu, Dec 13th 2018 ]: WOPRAI
[ Thu, Dec 13th 2018 ]: WOPRAI
[ Thu, Dec 13th 2018 ]: WOPRAI
[ Thu, Dec 13th 2018 ]: WOPRAI
[ Thu, Dec 13th 2018 ]: WOPRAI
[ Thu, Dec 13th 2018 ]: WOPRAI
Christopher Marai Maintained (SNDX) at Strong Buy with Decreased Target to $12 on, Dec 17th, 2018


🞛 This publication is a summary or evaluation of another publication
Christopher Marai of Nomura, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Decreased Target from $22 to $12 on, Dec 17th, 2018.
Christopher has made no other calls on SNDX in the last 4 months.
There are 2 other peers that have a rating on SNDX. Out of the 2 peers that are also analyzing SNDX, 1 agrees with Christopher's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Lebowitz of "Morgan Stanley" Downgraded from Buy to Hold on, Monday, October 29th, 2018
This is the rating of the analyst that currently disagrees with Christopher
- Joel Beatty of "Citigroup" Maintained at Strong Buy with Decreased Target to $12 on, Thursday, October 11th, 2018
Similar Stocks and Investing Publications
[ Fri, Dec 14th 2018 ]: WOPRAI
[ Tue, Dec 11th 2018 ]: WOPRAI
[ Fri, Dec 07th 2018 ]: WOPRAI
[ Tue, Dec 04th 2018 ]: WOPRAI
[ Mon, Oct 29th 2018 ]: WOPRAI
[ Tue, Oct 23rd 2018 ]: WOPRAI
[ Fri, Oct 19th 2018 ]: WOPRAI
[ Tue, Oct 16th 2018 ]: WOPRAI
[ Wed, Oct 03rd 2018 ]: WOPRAI
[ Mon, Sep 24th 2018 ]: WOPRAI
[ Thu, May 17th 2018 ]: WOPRAI
[ Fri, May 11th 2018 ]: WOPRAI